Clinical Trial Detail

NCT ID NCT00184015
Title Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
Recruitment Unknown status
Gender both
Phase
Variant Requirements no
Sponsors University of Southern California
Indications

kidney cancer

Therapies

Bevacizumab

Bortezomib

Age Groups: adult

No variant requirements are available.